SCOTT F LINDSEY

Allopathic & Osteopathic Physicians|Dermatology|MOHS-Micrographic Surgery TAMPA, FL NPI 1013317460

General Payments — all program years on this page

$3,121.70

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 100
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $570.10 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $570.1020

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,101.4831
2019 $460.788
2020 $110.882
2021 $302.8414
2022 $361.2516
2023 $214.379
2024 $570.1020

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087136092 Novartis Pharmaceuticals Corporation $25.68 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087136114 Novartis Pharmaceuticals Corporation $24.16 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087136118 Novartis Pharmaceuticals Corporation $19.29 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087136168 Novartis Pharmaceuticals Corporation $20.45 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104886401 ABBVIE INC. $29.95 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114101623 Regeneron Healthcare Solutions, Inc. $17.03 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114101625 Regeneron Healthcare Solutions, Inc. $22.87 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117612105 Amgen Inc. $28.35 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120098870 Kerecis Limited $22.81 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120101595 Kerecis Limited $27.70 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120109417 Kerecis Limited $16.86 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120634538 Almirall LLC $15.43 12/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1121072777 Arcutis Biotherapeutics, Inc. $18.27 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139881780 GENZYME CORPORATION $31.21 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143129808 UCB, Inc. $30.94 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145436628 Organogenesis Inc. $21.38 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152200657 SUN PHARMACEUTICAL INDUSTRIES INC. $148.16 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152200659 SUN PHARMACEUTICAL INDUSTRIES INC. $26.91 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152200661 SUN PHARMACEUTICAL INDUSTRIES INC. $14.88 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152200663 SUN PHARMACEUTICAL INDUSTRIES INC. $7.77 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.